Gynecologic Oncology
Jean A. Hurteau
Cervical, ovarian, and uterine cancer; minimally invasive surgery. Evanston, Highland Park. 847-570-2639
Ernst Lengyel
Endometrial, ovarian, and uterine cancer. Chicago. 773-702-6722
John R. Lurain III
Gestational trophoblastic disease; cervical, ovarian, and uterine cancer. Northwestern. 312-695-0990
Ronald K. Potkul
Cervical, ovarian, vulvar, and vaginal cancer; robotic surgery. Loyola. 708-216-3383
Gustavo C. Rodriguez
Cancer prevention; ovarian cancer; ovarian cancer (early detection). Evanston. 847-570-2639
Jacob Rotmensch
Cervical, endometrial, ovarian, and uterine cancer. Rush. 312-942-6300
S. Diane Yamada
Cervical, genital tract, ovarian, and uterine cancer; gynecologic cancer; minimally invasive surgery. Chicago. 773-702-6123
Medical Oncology
Kathy Sue Albain
Breast and lung cancer; cancer survivors (late effects of therapy); mesothelioma. Loyola. 708-327-3102
Kathy Albain
In her 30-plus-year career, Kathy Albain, 63, has led some 40 studies in the fight against lung and breast cancer. Last year alone, she fronted two landmark trials: the first to preserve fertility and prevent early menopause in young women undergoing treatments; the second, a decade in the making, to definitively prove that many breast cancer patients can safely avoid chemotherapy. Through gene analysis, doctors rate patients’ tumors on a scale from 1 to 100—the lower the score, the less likely the need for chemo. “These are some of the biggest concerns for women with breast cancer. It’s not the pain or the nausea anymore, we’ve got drugs for those,” Albain says. “This research helps us cut a lot of the debilitating side effects we couldn’t control before. Ultimately, these women will have a better quality of life both during and after treatment.”
Al Bowen Benson III
Colon, gastrointestinal, pancreatic, and rectal cancer. Northwestern. 312-695-0990
Michael R. Bishop
Leukemia and non-Hodgkin’s lymphoma; multiple myeloma; stem cell transplant. Chicago. 773-702-6149
Michael Bishop
Lengthy and isolating hospital stays are a thing of the past for some cancer patients at the University of Chicago Medicine’s outpatient blood and bone marrow stem cell transplant unit. Led by Michael Bishop, the key force behind its opening in 2014, the clinic allows patients to receive treatment and return daily to their families and the comforts of home. “When you’re getting up and moving around, the lungs are more expanded, the oxygenation is better, and organs perform better,” says Bishop, 56, who is also a leader in the area of relapse after stem cell transplants. “The No. 1 cause of death after transplantation is recurrence of disease,” he says. “Why does one patient go on to get to spend time with her kids, and the other one, nine months later, her disease comes back? Understanding the biology—this has been the true focus of my career.”
Jacob David Bitran
Breast and lung cancer; bone marrow transplant. Lutheran. 847-268-8200
Philip David Bonomi
Lung and thymic cancer; mesothelioma. Rush. 312-942-5904
Bruce Earl Brockstein
Head and neck cancer; melanoma; sarcoma. Evanston. 847-570-2112
Joseph Ignatius Clark
Head, kidney, and neck cancer; melanoma. Loyola. 708-327-3217
Joseph Clark is leading the first Midwest clinical trial of an experimental vaccine that trains melanoma patients’ immune systems to fight the cancer.
Melody Ann Cobleigh
Breast cancer. Rush. 312-942-5904
Suzanne D. Conzen
Breast cancer. Chicago. 773-702-6149
Gini F. Fleming
Breast cancer (novel therapies); gynecologic and ovarian cancer. Chicago. 773-702-6149
Ellen R. Gaynor
Bladder, breast, prostate, and testicular cancer. Loyola. 708-327-3214
William J. Gradishar
Breast cancer. Northwestern. 312-695-0990
Philip C. Hoffman
Lung and breast cancer. Chicago. 773-834-7424
Andrzej Jakubowiak
Multiple myeloma; bone marrow transplant. Chicago. 773-795-1180
Hedy Lee Kindler
Gastrointestinal and pancreatic cancer; mesothelioma. Chicago. 773-702-0360
Timothy M. Kuzel
Kidney and urologic cancer; non-Hodgkin’s lymphoma; melanoma. Northwestern. 312-695-0990
Chadi Nabhan
Hematologic malignancies; leukemia and lymphoma; prostate cancer. Chicago. 773-702-6149
Olufunmilayo I. Olopade
Breast cancer; breast cancer genetics; cancer risk assessment; hereditary cancer. Chicago. 773-702-6149
Howard Ozer
Leukemia; lymphoma. IHHSS. 312-355-1625
David J. Peace
Prostate cancer; Lymphoma; hematologic malignancies. IHHSS. 312-355-1625
Mark J. Ratain
Solid tumors; drug development; clinical trials. Chicago. 773-702-6149
Jon Morgan Richards
Melanoma. Lutheran, Skokie. 847-268-8200
Ravi Salgia
Lung and thoracic cancer; mesothelioma; carcinoid tumors. Chicago. 773-702-6149
Sonali M. Smith
Hodgkin’s lymphoma; lymphoma; non-Hodgkin’s; clinical trials; stem cell transplant. Chicago. 773-702-6149
Walter M. Stadler
Bladder, kidney, prostate, and testicular cancer. Chicago. 773-702-6149
Everett E. Vokes
Esophageal, head, lung, and neck cancer; gene therapy. Chicago. 773-702-6149
Radiation Oncology
Ross Allen Abrams
Gastrointestinal cancer; lymphoma; sarcoma (soft tissue). Rush. 312-942-5751
Azhar Mahmood Awan
Solid tumors; breast and prostate cancer; sarcoma (soft tissue). Sherman. 224-783-8746
Philip Paul Connell
Pediatric and thoracic cancers; sarcoma. Chicago. 773-702-6870
Bahman Emami
Lung, head, and neck cancer; acoustic neuroma. Loyola. 708-216-2729
Howard J. Halpern
Breast cancer; intensity-modulated radiotherapy (IMRT); image-guided radiation therapy (IGRT); brachytherapy; meningiomas. IHHSS. 312-996-3631
Daniel James Haraf
Lung, prostate, head, and neck cancer. Chicago. 773-702-6870
Bharat Bhushan Mittal
Head, neck, skin, and thyroid cancer; lymphoma. Northwestern. 312-926-2520
William Small Jr.
Breast, gastrointestinal, gynecologic, and pancreatic cancer. Loyola. 708-216-2729